Genzyme files patent infringement suit against DRL

Sep 23 2013, 02:57 IST
Comments 0
SummaryGenzyme, a fully-owned subsidiary of drug major Sanofi, has filed a suit against Dr Reddy’s Laboratories alleging that the Indian drug maker infringed patents of its cancer drug Mozobil on three counts

Genzyme, a fully-owned subsidiary of drug major Sanofi, has filed a suit against Dr Reddy’s Laboratories alleging that the Indian drug maker infringed patents of its cancer drug Mozobil on three counts. Mozobil (plerixafor injection) is a haematopoietic stem cell mobiliser indicated to patients with non-Hodgkin’s lymphoma (blood cancer) and multiple myeloma. In its petition filed in the District Court of Delaware, Genzyme alleged that DRL intimated though a letter that it had submitted an Abbreviated New Drug Application with the USFDA seeking a nod to engage in the commercial manufacture, import, use and sale of 20 mg/ml Plerixafor injection as a generic version of Mobozil.

Ads by Google

More from Frontpage

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...